Neurodevelopmental Dimensional Assessment and Genomic Risk of…

Neurodevelopmental Dimensional Assessment and Genomic Risk of Neuropsychiatric Conditions

Duration: 20 mins Publication Date: 12 Dec 2023 Next Review Date: 12 Dec 2026 DOI: 10.13056/acamh.25584

Description

In this Papers Podcast, Dr. Sam Chawner discusses his JCPP Advances paper ‘Neurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions’. Sam is the first author of the paper.

Learning Objectives

1. What are copy-number variants (CNVs) and how they impact child development.
2. Insight into what 22q11.2 deletion syndrome is, how it is typically diagnosed, and how it is associated with psychiatric risk.
3. Implications for clinicians and CAMH professionals.
4. Whether there are adequate interventions targeted at early age groups.
5. Recommendations for prevention, detection, and the targeting of interventions.

Paper Link

https://doi.org/10.1002/jcv2.12162

About this Lesson

Topics:

Audiences:

Populations:

Symptoms:

none

Publication Type:

Podcast

Level:

Speakers

Dr Samuel Chawner

Associate Professor in Biological Psychopathology at the Department of Child and Adolescent Psychiatry and Head of the inDEPTH Lab based at the Erasmus Medical Centre, the Netherlands

}